Detecting PAX2 for the diagnosis of breast cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 7, 2014
Grant Date -
Jan 24, 2013
app pub date -
Sep 7, 2012
filing date -
Jan 16, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method for monitoring breast conditions in a subject is disclosed. The method comprises determining a Paired Box 2 gene-to-beta defensin-1 gene (PAX2-to-DEFB1) expression ratio (the “Donald Predictive Factor” or “DPF”) in cells obtained from the breast of the subject, wherein the PAX2-to-DEFB1 expression ratio is correlated with breast conditions. Also disclosed is a kit for monitoring breast conditions and determining drug resistance.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully